A Closer Look at 11 Analyst Recommendations For Crinetics Pharmaceuticals
A Closer Look at 11 Analyst Recommendations For Crinetics Pharmaceuticals
对Crinetics制药公司的11个分析师建议进行更详细的分析
During the last three months, 11 analysts shared their evaluations of Crinetics Pharmaceuticals (NASDAQ:CRNX), revealing diverse outlooks from bullish to bearish.
在过去的三个月中，有11位分析师共享了他们对Crinetics Pharmaceuticals (NASDAQ:CRNX)的评估，展现了从看好到看淡的不同态度。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
Analysts have set 12-month price targets for Crinetics Pharmaceuticals, revealing an average target of $68.64, a high estimate of $97.00, and a low estimate of $54.00. This upward trend is evident, with the current average reflecting a 7.86% increase from the previous average price target of $63.64.
分析师为Crinetics Pharmaceuticals设定了12个月的目标价，揭示了平均目标价为68.64美元，最高估价为97.00美元，最低估价为54.00美元。这种上升趋势是明显的，当前的平均值反映了7.86%的增长，比先前的平均目标价63.64美元高。
Decoding Analyst Ratings: A Detailed Look
分析师评级解读：详细解析
An in-depth analysis of recent analyst actions unveils...
最近分析师行动的深...
登录免费看全文
登录/注册